SOURCES SOUGHT
A -- Antimicrobial Acquisition and Coordinating Facility
- Notice Date
- 5/21/2004
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700 B Rockledge Room 3214 MSC7612, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- N01-AI-95364-A
- Response Due
- 7/5/2004
- Archive Date
- 7/20/2004
- Point of Contact
- Karim Hourani, Contract Specialist, Phone 301-451-3690, Fax 301-402-0972, - Paul McFarlane, Senior Contracting Officer, Phone 301-496-0349, Fax 301-402-0972,
- E-Mail Address
-
KHourani@niaid.nih.gov, pm24v@nih.gov
- Description
- The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate, under the authority of 41 U.S.C. 253(c)(1) and FAR 6.302-1, a modification to increase the number of compounds to be acquired to 10,000 per year, increase the libraries from 1-2 per year and increase the number of laboratories to which the contractor will supply compounds for evaluation of the biological effects to its seven (7) year contract N01-AI-95364 with Southern Research Institute (Southern). The contract provides for the selective acquisition of synthetic and pure natural product compounds from a wide variety of sources and within a wide variety of chemical classes, including libraries of compounds. The contract?s title is the Antimicrobial Acquisition and Coordinating Facility. The Statement of Work includes the following activities: receiving and storing chemical compounds, verifying purity, maintaining a computerized registry of unique structures, obtaining screening agreements, providing secure and safe facilities and resources, executing confidentiality agreements, distributing specific aliquots of compounds to contract laboratories for biological testing against infectious agents, recording data from other laboratories, and maintaining correspondence associated with testing. The contract initially set a target of approximately 4,000 compounds per year and focused on tuberculosis, including drug resistant tuberculosis. Multiple Drug Resistant Tuberculosis (MDR-TB) is an NIH Bio-terrorism Category C agent. The planned expansion will include increasing the number of compounds to be acquired to 10,000 per year, increase the number of libraries from 1-2 per year and to increase the number of laboratories to which the contractor will supply compounds for evaluation of the biological effects. The biological testing will include new microbes; especially organisms considered agents of bioterrorism (Categories A though C) which have the potential to cause emerging and re-emerging diseases. This expansion is expected to be accomplished within the contract?s current performance period ending September 29, 2006. See Government-Wide Numbered Notes 22 and 26. No collect calls will be accepted.
- Place of Performance
- Address: Southern Research Institute, 2000 Ninth Avenue South, Birmingham, Alabama, ,
- Zip Code: 35255
- Country: United States
- Zip Code: 35255
- Record
- SN00590238-W 20040523/040521211821 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |